insights_auto
Why is DRUG up ၂.၅၆%?
Dive Deeperchevron_right
DRUG:NASDAQ
Bright Minds Biosciences Inc
၅၅.၂၀ US$
arrow_upward
+၂.၅၆%(+၁.၃၈) 1D
အောက် ၂၀, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
၅၄.၀၀ US$
High
၅၇.၅၀ US$
Low
၅၄.၀၀ US$
Mkt. cap
၇၈.၁၇ ကုဋေ
Avg. vol.
၁.၂၈ သိန်း
Volume
၀.၀၀
52-wk high
၁၂၃.၇၅ US$
52-wk low
၄၇.၃၅ US$
Beta
-၅.၂၁
Shares outstanding
၉.၈၆ သန်း
No. of employees
၂၆
Open
၅၄.၀၀ US$
High
၅၇.၅၀ US$
Low
၅၄.၀၀ US$
Mkt. cap
၇၈.၁၇ ကုဋေ
Avg. vol.
၁.၂၈ သိန်း
Volume
၀.၀၀
52-wk high
၁၂၃.၇၅ US$
52-wk low
၄၇.၃၅ US$
Beta
-၅.၂၁
Shares outstanding
၉.၈၆ သန်း
No. of employees
၂၆
News stories
From web sources and news partners
MarketBeat
·
ပြီးခဲ့သည့် ၇ မိနစ်
First Internet Bancorp (NASDAQ:INBK) Stock Breaks Below 200-Day Moving Average - What's Next?
Crypto News
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
BNB Standard to ring Nasdaq opening bell on October 26 under new CEO
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
The Top 15 Stocks in the S&P 500 Are Now 47% of the Value. In 2000 Bubble, It Was 27%
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Futures: SpaceX, Supermicro Revive AI Stocks; Tesla, Meta On Deck
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc